OKLO · Oklo Inc.

Coverage refresh. The prior note named a daily close below $38.83 as the structural break. That level went on 2026-09-01 at $38.53, and was taken back one session later at $39.52 on 2026-09-02. What moved in between was not the price but the reported scope of the FERC dispute.

OKLO — Oklo Inc.

Current Thesis

The leg an investor is buying is second-order AI power: datacenter electricity demand routed through the first private US developer to take a greenfield reactor critical under the Department of Energy pilot pathway, with Groves reaching first criticality on 2026-08-06. The 2026-09-01 selloff came out of FERC Docket EL26-101-000, filed 2026-08-28, after PJM notified Oklo on 2026-08-03 that a 750 MW hybrid request — 150 MW advanced nuclear, 300 MW fuel cells, 300 MW natural gas — had been pulled from the Cycle 1 interconnection study, partly because the project never demonstrated ride-through of a sudden grid-voltage drop.

Reporting on what was actually withdrawn diverges, and the divergence is the new information since the last note. Utility Dive (2026-08-31) and 247wallst (2026-09-01, "Oklo Sinks 5% as PJM Pulls Its Meta-Backed Ohio Project") tie the request to the Meta-backed 1.2 GW Pike County, Ohio campus and to Oklo's claim of a delay of at least 14 months. The American Nuclear Society's 2026-09-02 account places the interconnection points at the Possum Point and Ladysmith substations in Virginia, north of Richmond, states the project was "until now, unknown to the public," and quotes Oklo's communications head that the filing "should not be understood as a deployment announcement, final investment decision, or commitment to a particular generation configuration." Those two descriptions cannot both be complete. The inference — not a measured fact — is that the tape sold a cancelled Meta deployment on 2026-09-01 and the ANS detail on 2026-09-02 shrank the commercial content of the headline, which is consistent with the shelf being retaken the same day.

The narrative is saturated: 25-plus sell-side firms already carry the name per Investing.com's consensus page, four price targets came down between 2026-08-10 and 2026-08-20, the 11.5% session of 2026-08-25 was sourced from US–Canada trade friction and a bid across uranium miners rather than any Oklo release and was fully retraced by 2026-08-28, and the first genuinely new company-specific information since the 2026-08-07 print reached the market through a regulatory docket. Data providers place the next company-controlled event, the Q3 print, at roughly 2026-11-18 — about eleven weeks with nothing scheduled from the company.

Bullish and bearish views on Oklo Inc.

The model's bull view on Oklo Inc. (OKLO), in brief: Groves first criticality on 2026-08-06 is an operating step no other US private microreactor developer has taken, eleven working days after DOE startup authorization on 2026-07-23. The bear view: The PJM withdrawal notice is dated 2026-08-03 and reached the tape twenty-five days later through a docket. Both cases follow in full.

Bull Case

• Groves first criticality on 2026-08-06 is an operating step no other US private microreactor developer has taken, eleven working days after DOE startup authorization on 2026-07-23.
• Four dated DOE-pathway approvals cleared inside ten weeks: Aurora-INL Preliminary Documented Safety Analysis 2026-06-11, Groves final safety analysis 2026-07-01, startup authorization 2026-07-23, first criticality 2026-08-06. None of them routes through the PJM queue.
• Cash and marketable securities of $3.0B at 2026-06-30 ($1.6B cash, $1.4B securities) versus $2.54B at 2026-03-31, generating $44.5M of H1 interest and dividend income against an H1 net loss of $81.6M. FY2026 guides are $120–150M operating cash use and $400–500M capex, so funding is not the binding constraint on a multi-quarter interconnection slip.
• Revenue is booked rather than modelled: $1.210M in Q2 2026 against a $126,250 consensus, with management guiding first isotope revenue from the NRC-licensed Idaho Radiochemistry Laboratory to roughly H1 2027 on the 2026-08-07 call.
• PJM's answer in EL26-101-000 is due 2026-09-04, and the stated defect — unproven voltage ride-through — is the kind of engineering deficiency that can be cured inside a study cycle. Oklo's complaint argues PJM's tariff requires deficiencies to be flagged promptly with an opportunity to cure, and points to PJM's 24 June NextGen comments.
• That is still enough borrow to give theme sessions mechanical lift, as on 2026-08-25.
• Sell-side dispersion remains wide and above the market: TipRanks shows a $90 average target from 10 Buys and six Holds with a $30–$175 range; Investing.com's 25-analyst consensus target is $79.88 with a $14–$130 range.

Bear Case

• The PJM withdrawal notice is dated 2026-08-03 and reached the tape twenty-five days later through a docket. Adverse operational facts arriving via FERC before the company addresses them is a disclosure pattern, and the Virginia project described by ANS on 2026-09-02 had never been disclosed at all.
• Insider supply runs on a schedule, not on news: Rule 10b5-1 plans adopted 2025-03-31 execute on the first business day of most months. The 2026-08-03 Form 4s show CEO Jacob DeWitte disposing of 120,000 Class A shares for roughly $4.9M direct and indirect, and Cochran entities selling 40,000 at $41.35, 16,500 at $38.55 and 3,500 at $39.60.
• A $1.0B at-the-market equity programme has been live since the 2026-05-13 424B5, so any strength can be met with issuance without a new announcement.
• Q2 2026 EPS came in at -$0.28 against -$0.16 estimated and the shares fell 7.7% on the print. Four targets followed: Canaccord $125 to $100 (Buy), Citigroup $76 to $57.50 (Neutral), Truist $55 to $51 (Hold) on 2026-08-10, and Texas Capital $93 to $89 (Buy) on 2026-08-20.
• With Q2 revenue of $1.210M, conventional earnings and sales multiples carry no information on this name; the entire valuation rests on dates that are not yet fixed.
• The Section 16 group widened on 2026-07-27 and five newly elevated executive officers filed initial Form 3s on 2026-08-04, broadening the future insider-filing flow.

Setup & Price Structure

The 2026-09-02 close of $39.52 sits 77.3% below the $174.14 52-week high, with a three-month price change of -39.6% and RSI(14) at 36.0 — weak, but not an oversold reading. The structure is a one-session break and reclaim: $38.83 was the shelf built off the 2026-07-29 low, it broke at $38.53 on 2026-09-01, and it was recovered at $39.52 on 2026-09-02. Below that shelf the only reference is the $36.61 52-week low; above it, the 2026-08-04 close of $43.33 caps the August range that the 2026-08-25 spike failed to clear on a closing measure.

Positioning observables, stated as observables: 25-plus firms cover the name and four of them cut targets inside eleven days in August; short interest was 17.80% of float at the 2026-08-14 settlement, a figure that describes positioning roughly two weeks stale because FINRA publishes on a settlement lag; retail-attention coverage clustered on 2026-08-26, when Benzinga listed OKLO among five stocks "on investors' radars" after a session driven by trade headlines rather than company news; a $1.0B ATM stands undrawn as far as disclosure shows; and there is no earnings date inside the next thirty days to force a repricing either way. The base under $38.83 has one session of age, which is not enough structure to call it held.

Catalyst Calendar (next 30 days)

• ~2026-09-25 (est.) — FINRA short interest for the 2026-09-15 settlement. First reading fully containing the PJM headline and the break-and-reclaim of $38.83.
• ~2026-10-01 (est.) — Next monthly founder tranche on the 10b5-1 cadence adopted 2025-03-31: scheduled supply inside a disclosure vacuum, near the $36.61 low.
• Outside the window, and worth dating anyway: the Q3 print at roughly 2026-11-18 is the next company-controlled event of any kind. No FERC order date in EL26-101-000 has been set.

Elapsed catalysts

• 2026-09-04 — PJM's answer due at FERC in Docket EL26-101-000. The first dated, third-party response to Oklo's reinstatement request and its claimed 14-month delay. (passed 7d ago)
• ~2026-09-10 (est.) — FINRA semi-monthly short interest for the 2026-08-31 settlement. The window closes before the 2026-09-01 break. (passed 1d ago)

What Would Change Our Mind

The structure that matters now is the $36.61 52-week low, because the 2026-09-01 session proved the $38.83 shelf can be lost on a single third-party filing. A daily close below $36.61 prints a new 52-week low with no prior reference beneath it and turns the August range into a distribution shelf rather than a base. The secondary condition is the 2026-09-04 answer date passing with PJM's position unchanged and no FERC direction to reinstate: at that point the 14-month delay Oklo claims becomes the working assumption for the largest disclosed offtake-linked project, inside eleven weeks with no company disclosure scheduled to argue against it.

On the other side, the read that the 2026-09-01 break was a headline event rather than a change in the deployment plan is confirmed by a daily close back above $43.33, which would restore the whole August range and place the FERC docket back into the category of process noise. A further datapoint that would flip the constructive case regardless of price: an open-market Form 4 outside the monthly 10b5-1 cadence from the CFO or from any of the five executives who filed initial Form 3s on 2026-08-04, or a disclosed drawdown on the $1.0B ATM.

Correlation Notes

• The 2026-08-25 session came from US–Canada trade friction lifting uranium miners and advanced-nuclear developers together (Benzinga, 2026-08-25); it carried no Oklo release, and it was retraced by 2026-08-28. Theme beta, not company news, has driven the largest up-sessions of the past month.
• The 2026-09-01 move was idiosyncratic in the other direction: 247wallst reported NuScale "barely budged" the same day, so the interconnection item did not travel across the group.
• Rates remain a live discount-rate input for cash flows dated 2028 and later. Long-end Treasury yields snapped back toward 20-month highs on 2026-08-20 and eased on 2026-08-25.
• Holtec's nuclear IPO (S-1 filed 2026-07-10, Nasdaq ticker HNUC, estimated $2.0B raise, no price range set as of 2026-08-24) would set a market-clearing price for a revenue-generating nuclear comparable and competes for the same theme allocations that fund pre-commercial developers.
• Hyperscaler datacenter capex is the demand anchor for the whole leg; the Meta linkage reported by Utility Dive and 247wallst is what made a queue-position dispute a five-percent equity event.